Riesgo de las enfermedades tromboembólicas venosas de los fármacos oncológicos - page 3

Variability of the VTE-Risk
VTE-Risk modifiers
Patient-related factors
Older age
Gender
Race
Higher in African Americans
Lower in Asians
Patient comorbidities
History of VTE
Cancer-related factors
Site of cancer
Stage
Initial period after diagnosis
Treatment-related factors
Major surgery
Hospitalization
Chemotherapy
Central venous catheters
Hormonal therapy
Antiangiogenic agents
ESAs
Transfusions
Rao MV et al. In Khorana and Francis, eds. Cancer-associated thrombosis;2007
1,2 4,5,6,7,8,9,10,11,12,13,...23
Powered by FlippingBook